Health
Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial – News-Medical.Net
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India — one of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
Noosa News23 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General19 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General13 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore
-
General22 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity